Obermatt
See Similar Stocks →

BridgeBio Oncology Therapeutics

NMQ:BBOT · US1079241022
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings38
Price/Book49
Dividend Yield—
Revenue Growth—
Profit Growth30
Capital Growth1
TSR 52w12
Leverage88
Liquidity33
Refinancing31
Combined—
Analyst Opinions43
Pro Holdings39
Opinion Changes88
Market Pulse9

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded2016
Websitebbotx.com
ISINUS1079241022
Last UpdateApr 2, 2026
Index & Theme
PulmonologyChronic DiseasesOncologyBiopharmaTherapeutics

Description

BridgeBio Oncology Therapeutics, Inc. (BBOT) operates as a clinical-stage biopharmaceutical company. BridgeBio Pharma, Inc. is a commercial-stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to tr…

Similar Stocks

The companies this stock is ranked against.

Compare BridgeBio Oncology Therapeutics with its peers
Acrivon Therapeutics
NMQ:ACRV
6
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Fate Therapeutics
NMQ:FATE
29
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Zentalis Pharmaceuticals
NMQ:ZNTL
12
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Elicio Therapeutics
NAQ:ELTX
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
BIOAGE Labs
NSQ:BIOA
23
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Immuneering
NMQ:IMRX
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →